Abstract
Identification of mutant proteins in biological samples is one of the emerging areas of proteogenomics. Despite the fact that only a limited number of studies have been published up to now, it has the potential to recognize novel disease biomarkers that have unique structure and desirably high specificity. Such properties would identify mutant proteoforms related to diseases as optimal drug targets useful for future therapeutic strategies. While mass spectrometry has demonstrated its outstanding analytical power in proteomics, the most frequently applied bottom-up strategy is not suitable for the detection of mutant proteins if only databases with consensus sequences are searched. It is likely that many unassigned tandem mass spectra of tryptic peptides originate from single amino acid variants (SAAVs). To address this problem, a couple of protein databases have been constructed that include canonical and SAAV sequences, allowing for the observation of mutant proteoforms in mass spectral data for the first time. Since the resulting large search space may compromise the probability of identifications, a novel concept was proposed that included identification as well as verification strategies. Together with transcriptome based approaches, targeted proteomics appears to be a suitable method for the verification of initial identifications in databases and can also provide quantitative insights to expression profiles, which often reflect disease progression. Important applications in the field of mutant proteoform identification have already highlighted novel biomarkers in large-scale investigations.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Anderson, N. L., Anderson, N. G., Haines, L. R., Hardie, D. B., Olafson, R. W., & Pearson, T. W. (2004). Mass spectrometric quantitation of peptides and proteins using Stable Isotope Standards and Capture by Anti-Peptide Antibodies (SISCAPA). Journal of Proteome Research, 3(2), 235–244.
Bamford, S., Dawson, E., Forbes, S., Clements, J., Pettett, R., Dogan, A., Flanagan, A., Teague, J., Futreal, P. A., Stratton, M. R., & Wooster, R. (2004). The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website. British Journal of Cancer, 91(2), 355–358.
Bozic, I., Antal, T., Ohtsuki, H., Carter, H., Kim, D., Chen, S., Karchin, R., Kinzler, K. W., Vogelstein, B., & Nowak, M. A. (2010). Accumulation of driver and passenger mutations during tumor progression. Proceedings of the National Academy of Sciences, 107(43), 18545–18550.
Bunger, M. K., Cargile, B. J., Sevinsky, J. R., Deyanova, E., Na, Y., Hendrickson, R. C., & Stephenson, J. L. (2007). Detection and validation of non-synonymous coding SNPs from orthogonal analysis of shotgun proteomics data. Journal of Proteome Research, 6, 2331–2340.
Chen, R., Mias, G. I., Li-Pook-Than, J., Jiang, L., Lam, H. Y. K., Chen, R., Miriami, E., Karczewski, K. J., Hariharan, M., Dewey, F. E., Cheng, Y., Clark, M. J., Im, H., Habegger, L., Balasubramanian, S., O'Huallachain, M., Dudley, J. T., Hillenmeyer, S., Haraksingh, R., Sharon, D., Euskirchen, G., Lacroute, P., Bettinger, K., Boyle, A. P., Kasowski, M., Grubert, F., Seki, S., Garcia, M., Whirl-Carrillo, M., Gallardo, M., Blasco, M. A., Greenberg, P. L., Snyder, P., Klein, T. E., Altman, R. B., Butte, A. J., Ashley, E. A., Gerstein, M., Nadeau, K. C., Tang, H., & Snyder, M. (2012). Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell, 148(6), 1293–1307.
Comprehensive genomic characterization defines human glioblastoma genes and core pathways (2008). Nature, 455(7216), 1061–1068.
Feng, Y., & Picotti, P. (2016). Selected reaction monitoring to measure proteins of interest in complex samples: A practical guide. Methods in Molecular Biology (Clifton, NJ), 1394, 43–56.
Frazer KA, Ballinger DG, Cox DR, Hinds DA, Stuve LL, Gibbs RA, Belmont JW, Boudreau A, Hardenbol P, Leal SM, Pasternak S, Wheeler DA, Willis TD, Yu F, Yang H, Zeng C, Gao Y, Hu H, Hu W, Li C, Lin W, Liu S, Pan H, Tang X, Wang J, Wang W, Yu J, Zhang B, Zhang Q, Zhao H, Zhao H, Zhou J, Gabriel SB, Barry R, Blumenstiel B, Camargo A, Defelice M, Faggart M, Goyette M, Gupta S, Moore J, Nguyen H, Onofrio RC, Parkin M, Roy J, Stahl E, Winchester E, Ziaugra L, Altshuler D, Shen Y, Yao Z, Huang W, Chu X, He Y, Jin L, Liu Y, Shen Y, Sun W, Wang H, Wang Y, Wang Y, Xiong X, Xu L, Waye MMY, Tsui SKW, Xue H, Wong JT-F, Galver LM, Fan J-B, Gunderson K, Murray SS, Oliphant AR, Chee MS, Montpetit A, Chagnon F, Ferretti V, Leboeuf M, Olivier J-F, Phillips MS, Roumy S, Sallée C, Verner A, Hudson TJ, Kwok P-Y, Cai D, Koboldt DC, Miller RD, Pawlikowska L, Taillon-Miller P, Xiao M, Tsui L-C, Mak W, Song YQ, Tam PKH, Nakamura Y, Kawaguchi T, Kitamoto T, Morizono T, Nagashima A, Ohnishi Y, Sekine A, Tanaka T, Tsunoda T, Deloukas P, Bird CP, Delgado M, Dermitzakis ET, Gwilliam R, Hunt S, Morrison J, Powell D, Stranger BE, Whittaker P, Bentley DR, Daly MJ, de Bakker PIW, Barrett J, Chretien YR, Maller J, McCarroll S, Patterson N, Pe'er I, Price A, Purcell S, Richter DJ, Sabeti P, Saxena R, Schaffner SF, Sham PC, Varilly P, Stein LD, Krishnan L, Smith AV, Tello-Ruiz MK, Thorisson GA, Chakravarti A, Chen PE, Cutler DJ, Kashuk CS, Lin S, Abecasis GR, Guan W, Li Y, Munro HM, Qin ZS, Thomas DJ, McVean G, Auton A, Bottolo L, Cardin N, Eyheramendy S, Freeman C, Marchini J, Myers S, Spencer C, Stephens M, Donnelly P, Cardon LR, Clarke G, Evans DM, Morris AP, Weir BS, Mullikin JC, Sherry ST, Feolo M, Skol A, Zhang H, Matsuda I, Fukushima Y, Macer DR, Suda E, Rotimi CN, Adebamowo CA, Ajayi I, Aniagwu T, Marshall PA, Nkwodimmah C, Royal CDM, Leppert MF, Dixon M, Peiffer A, Qiu R, Kent A, Kato K, Niikawa N, Adewole IF, Knoppers BM, Foster MW, Clayton EW, Watkin J, Muzny D, Nazareth L, Sodergren E, Weinstock GM, Yakub I, Birren BW, Wilson RK, Fulton LL, Rogers J, Burton J, Carter NP, Clee CM, Griffiths M, Jones MC, McLay K, Plumb RW, Ross MT, Sims SK, Willey DL, Chen Z, Han H, Kang L, Godbout M, Wallenburg JC, L'Archevêque P, Bellemare G, Saeki K, Wang H, An D, Fu H, Li Q, Wang Z, Wang R, Holden AL, Brooks LD, McEwen JE, Guyer MS, Wang VO, Peterson JL, Shi M, Spiegel J, Sung LM, Zacharia LF, Collins FS, Kennedy K, Jamieson R, Stewart J (2007) A second generation human haplotype map of over 3.1 million SNPs. Nature 449 (7164):851–861.
Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: Recommendation statement. (2005). Annals of internal medicine 143 (5):355–361
Gimelbrant, A., Hutchinson, J. N., Thompson, B. R., & Chess, A. (2007). Widespread monoallelic expression on human autosomes. Science, 318(5853), 1136–1140.
Greenman, C., Stephens, P., Smith, R., Dalgliesh, G. L., Hunter, C., Bignell, G., Davies, H., Teague, J., Butler, A., Stevens, C., Edkins, S., O'Meara, S., Vastrik, I., Schmidt, E. E., Avis, T., Barthorpe, S., Bhamra, G., Buck, G., Choudhury, B., Clements, J., Cole, J., Dicks, E., Forbes, S., Gray, K., Halliday, K., Harrison, R., Hills, K., Hinton, J., Jenkinson, A., Jones, D., Menzies, A., Mironenko, T., Perry, J., Raine, K., Richardson, D., Shepherd, R., Small, A., Tofts, C., Varian, J., Webb, T., West, S., Widaa, S., Yates, A., Cahill, D. P., Louis, D. N., Goldstraw, P., Nicholson, A. G., Brasseur, F., Looijenga, L., Weber, B. L., Chiew, Y. E., DeFazio, A., Greaves, M. F., Green, A. R., Campbell, P., Birney, E., Easton, D. F., Chenevix-Trench, G., Tan, M. H., Khoo, S. K., Teh, B. T., Yuen, S. T., Leung, S. Y., Wooster, R., Futreal, P. A., & Stratton, M. R. (2007). Patterns of somatic mutation in human cancer genomes. Nature, 446(7132), 153–158.
Haber, D. A., & Settleman, J. (2007). Cancer: Drivers and passengers. Nature, 446(7132), 145–146.
Hammarström, P., Wiseman, R. L., Powers, E. T., & Kelly, J. W. (2003). Prevention of transthyretin amyloid disease by changing protein misfolding energetics. Science (New York, NY), 299(5607), 713–716.
Hamosh, A., Scott, A. F., Amberger, J. S., Bocchini, C. A., & McKusick, V. A. (2005). Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Research, 33(Database issue), D514–517.
Kawabata, T., Ota, M., & Nishikawa, K. (1999). The protein mutant database. Nucleic Acids Research, 27(1), 355–357.
Kovanich, D., Cappadona, S., Raijmakers, R., Mohammed, S., Scholten, A., & Heck, A. J. (2012). Applications of stable isotope dimethyl labeling in quantitative proteomics. Analytical and Bioanalytical Chemistry, 404(4), 991–1009.
Li, J., Duncan, D. T., & Zhang, B. (2010). CanProVar: A human cancer proteome variation database. Human Mutation, 31(3), 219–228.
Li, J., Su, Z., Ma, Z. Q., Slebos, R. J. C., Halvey, P., Tabb, D. L., Liebler, D. C., Pao, W., & Zhang, B. (2011). A bioinformatics workflow for variant peptide detection in shotgun proteomics. Molecular & Cellular Proteomics, 10(5), M110.006536–M006110.006536.
Lichti, C. F., Mostovenko, E., Wadsworth, P. A., Lynch, G. C., Pettitt, B. M., Sulman, E. P., Wang, Q., Lang, F. F., Rezeli, M., Marko-Varga, G., Végvári, Á., & Nilsson, C. L. (2015). Systematic identification of single amino acid variants in Glioma stem-cell-derived chromosome 19 proteins. Journal of Proteome Research, 14(2), 778–786.
Lopez, M. F., Rezai, T., Sarracino, D. A., Prakash, A., Krastins, B., Athanas, M., Singh, R. J., Barnidge, D. R., Oran, P., Borges, C., & Nelson, R. W. (2010). Selected reaction monitoring-mass spectrometric immunoassay responsive to parathyroid hormone and related variants. Clinical Chemistry, 56(2), 281–290.
Magrane, M., & Consortium, U. (2011). UniProt knowledgebase: A hub of integrated protein data. Database 2011, bar009.
Mathivanan, S., Ji, H., Tauro, B. J., Chen, Y.-S, & Simpson, R. J. (2012). Identifying mutated proteins secreted by colon cancer cell lines using mass spectrometry. Journal of Proteomics, 76, 141–149.
Montgomery, S. B., Sammeth, M., Gutierrez-Arcelus, M., Lach, R. P., Ingle, C., Nisbett, J., Guigo, R., & Dermitzakis, E. T. (2010). Transcriptome genetics using second generation sequencing in a Caucasian population. Nature, 464(7289), 773–777.
Nesvizhskii, A. I., Roos, F. F., Grossmann, J., Vogelzang, M., Eddes, J. S., Gruissem, W., Baginsky, S., & Aebersold, R. (2006). Dynamic spectrum quality assessment and iterative computational analysis of shotgun proteomic data: toward more efficient identification of post-translational modifications, sequence polymorphisms, and novel peptides. Molecular & Cellular Proteomics, 5(4), 652–670.
Nie, S., Yin, H., Tan, Z., Anderson, M. A., Ruffin, M. T., Simeone, D. M., & Lubman, D. M. (2014). Quantitative analysis of single amino acid variant peptides associated with pancreatic cancer in serum by an isobaric labeling quantitative method. Journal of Proteome Research, 13(12), 6058–6066.
Nørregaard Jensen, O. (2004). Modification-specific proteomics: Characterization of post-translational modifications by mass spectrometry. Current Opinion in Chemical Biology, 8(1), 33–41.
O'Donovan, C., Apweiler, R., & Bairoch, A. (2001). The human proteomics initiative (HPI). Trends in Biotechnology, 19(5), 178–181.
Omenn, G. S., Lane, L., Lundberg, E. K., Beavis, R. C., Nesvizhskii, A. I., & Deutsch, E. W. (2015). Metrics for the Human Proteome Project 2015: Progress on the human proteome and guidelines for high-confidence protein identification. Journal of Proteome Research, 14(9), 3452–3460.
Paik, Y. K., Omenn, G. S., Uhlen, M., Hanash, S., Marko-Varga, G., Aebersold, R., Bairoch, A., Yamamoto, T., Legrain, P., Lee, H. J., Na, K., Jeong, S. K., He, F., Binz, P. A., Nishimura, T., Keown, P., Baker, M. S., Yoo, J. S., Garin, J., Archakov, A., Bergeron, J., Salekdeh, G. H., & Hancock, W. S. (2012). Standard guidelines for the chromosome-centric human proteome project. Journal of Proteome Research, 11(4), 2005–2013.
Pandey, A., & Pevzner, P. A. (2014). Proteogenomics. Proteomics, 14(23–24), 2631–2632.
Salisbury, B. A., Pungliya, M., Choi, J. Y., Jiang, R., Sun, X. J., & Stephens, J. C. (2003). SNP and haplotype variation in the human genome. Mutation Research, 526, 53–61.
Schandorff, S., Olsen, J. V., Bunkenborg, J., Blagoev, B., Zhang, Y., Andersen, J. S., & Mann, M. (2007). A mass spectrometry-friendly database for cSNP identification. Nature Methods, 4, 465–466.
Sherry, S. T., Ward, M. H., Kholodov, M., Baker, J., Phan, L., Smigielski, E. M., & Sirotkin, K. (2001). dbSNP: The NCBI database of genetic variation. Nucleic Acids Research, 29, 308–311.
Shi, T., Fillmore, T. L., Sun, X., Zhao, R., Schepmoes, A. A., Hossain, M., Xie, F., Wu, S., Kim, J. S., Jones, N., Moore, R. J., Pasa-Tolic, L., Kagan, J., Rodland, K. D., Liu, T., Tang, K., Camp, D. G., 2nd, Smith, R. D., & Qian, W. J. (2012). Antibody-free, targeted mass-spectrometric approach for quantification of proteins at low picogram per milliliter levels in human plasma/serum. Proceedings of the National Academy of Sciences of the United States of America, 109(38), 15395–15400.
Sjoblom, T., Jones, S., Wood, L. D., Parsons, D. W., Lin, J., Barber, T. D., Mandelker, D., Leary, R. J., Ptak, J., Silliman, N., Szabo, S., Buckhaults, P., Farrell, C., Meeh, P., Markowitz, S. D., Willis, J., Dawson, D., Willson, J. K., Gazdar, A. F., Hartigan, J., Wu, L., Liu, C., Parmigiani, G., Park, B. H., Bachman, K. E., Papadopoulos, N., Vogelstein, B., Kinzler, K. W., & Velculescu, V. E. (2006). The consensus coding sequences of human breast and colorectal cancers. Science, 314(5797), 268–274.
Song, C., Wang, F., Cheng, K., Wei, X., Bian, Y., Wang, K., Tan, Y., Wang, H., Ye, M., & Zou, H. (2014). Large-scale quantification of single amino-acid variations by a variation-associated database search strategy. Journal of Proteome Research, 13(1), 241–248.
Sordella, R., Bell, D. W., Haber, D. A., & Settleman, J. (2004). Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways. Science, 305(5687), 1163–1167.
Su, Z. D., Sun, L., Yu, D. X., Li, R. X., Li, H. X., Yu, Z. J., Sheng, Q. H., Lin, X., Zeng, R., & Wu, J. R. (2011). Quantitative detection of single amino acid polymorphisms by targeted proteomics. Journal of Molecular Cell Biology, 3(5), 309–315.
Sun, T., Zhou, Y., Yang, M., Hu, Z., Tan, W., Han, X., Shi, Y., Yao, J., Guo, Y., Yu, D., Tian, T., Zhou, X., Shen, H., & Lin, D. (2008). Functional genetic variations in cytotoxic T-lymphocyte antigen 4 and susceptibility to multiple types of cancer. Cancer Research, 68(17), 7025–7034.
Tabas-Madrid, D., Alves-Cruzeiro, J., Segura, V., Guruceaga, E., Vialas, V., Prieto, G., Garcia, C., Corrales, F. J., Albar, J. P., & Pascual-Montano, A. (2015). Proteogenomics dashboard for the human proteome project. Journal of Proteome Research, 14(9), 3738–3749.
Taylor, R. W., & Turnbull, D. M. (2005). Mitochondrial DNA mutations in human disease. Nature Reviews Genetics, 6(5), 389–402.
Végvári, Á., Sjödin, K., Rezeli, M., Malm, J., Lilja, H., Laurell, T., & Marko-Varga, G. (2013). Identification of a novel proteoform of prostate specific antigen (SNP-L132I) in clinical samples by multiple reaction monitoring. Molecular & Cellular Proteomics, 12(10), 2761–2773.
Wang, X., & Zhang, B. (2013). CustomProDB: An R package to generate customized protein databases from RNA-Seq data for proteomics search. Bioinformatics (Oxford, UK), 29(24), 3235–3237.
Wang, Q., Chaerkady, R., Wu, J., Hwang, H. J., Papadopoulos, N., Kopelovich, L., Maitra, A., Matthaei, H., Eshleman, J. R., Hruban, R. H., Kinzler, K. W., Pandey, A., & Vogelstein, B. (2011). Mutant proteins as cancer-specific biomarkers. Proceedings of the National Academy of Sciences, 108(6), 2444–2449.
Whiteaker, J. R., Zhao, L., Zhang, H. Y., Feng, L. C., Piening, B. D., Anderson, L., & Paulovich, A. G. (2007). Antibody-based enrichment of peptides on magnetic beads for mass-spectrometry-based quantification of serum biomarkers. Analytical Biochemistry, 362(1), 44–54.
Whiteaker, J. R., Zhao, L., Abbatiello, S. E., Burgess, M., Kuhn, E., Lin, C., Pope, M. E., Razavi, M., Anderson, N. L., Pearson, T. W., Carr, S. A., & Paulovich, A. G. (2011). Evaluation of large scale quantitative proteomic assay development using peptide affinity-based mass spectrometry. Molecular & Cellular Proteomics, 10(4), M110.005645.
Wood, L. D., Parsons, D. W., Jones, S., Lin, J., Sjoblom, T., Leary, R. J., Shen, D., Boca, S. M., Barber, T., Ptak, J., Silliman, N., Szabo, S., Dezso, Z., Ustyanksky, V., Nikolskaya, T., Nikolsky, Y., Karchin, R., Wilson, P. A., Kaminker, J. S., Zhang, Z., Croshaw, R., Willis, J., Dawson, D., Shipitsin, M., Willson, J. K., Sukumar, S., Polyak, K., Park, B. H., Pethiyagoda, C. L., Pant, P. V., Ballinger, D. G., Sparks, A. B., Hartigan, J., Smith, D. R., Suh, E., Papadopoulos, N., Buckhaults, P., Markowitz, S. D., Parmigiani, G., Kinzler, K. W., Velculescu, V. E., & Vogelstein, B. (2007). The genomic landscapes of human breast and colorectal cancers. Science (New York, NY), 318(5853), 1108–1113.
Xi, H., Park, J., Ding, G., Lee, Y. H., & Li, Y. (2009). SysPIMP: The web-based systematical platform for identifying human disease-related mutated sequences from mass spectrometry. Nucleic Acids Research, 37(Database issue), D913–920.
Yan, H., Yuan, W., Velculescu, V. E., Vogelstein, B., & Kinzler, K. W. (2002). Allelic variation in human gene expression. Science, 297(5584), 1143.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Végvári, Á. (2016). Mutant Proteogenomics. In: Végvári, Á. (eds) Proteogenomics. Advances in Experimental Medicine and Biology, vol 926. Springer, Cham. https://doi.org/10.1007/978-3-319-42316-6_6
Download citation
DOI: https://doi.org/10.1007/978-3-319-42316-6_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-42314-2
Online ISBN: 978-3-319-42316-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)